文献速递耳科与耳神经小儿耳鼻咽喉

儿童细菌性脑膜炎所致听力损失发生率随时间下降:一项数据库回顾性研究

Decrease in Rates of Hearing Loss From Pediatric Bacterial Meningitis Over Time: A Database Review.
PubMed 文献 · Laryngoscope · 2024-02-24

该研究基于2010至2022年儿科健康信息系统数据库,回顾性分析6138例细菌性脑膜炎患儿,其中277例(4.51%)诊断为听力损失。研究发现肺炎链球菌、流感嗜血杆菌和脑膜炎奈瑟菌感染与更高的听力损失率相关,地塞米松使用与听力损失率降低无关,但研究期间听力和死亡率均显著下降。

要点

  • 6138例细菌性脑膜炎患儿中277例(4.51%)出现听力损失,总体死亡率为2.1%。
  • 听力损失组年龄显著大于无听力损失组(23.6个月 vs 5.3个月,p<0.01)。
  • 研究期间听力损失和死亡率均呈显著下降趋势,但地塞米松与听力损失率降低无关。

核心结论

  • 尽管针对肺炎链球菌、流感嗜血杆菌和脑膜炎奈瑟菌的疫苗已广泛接种,听力损失仍是细菌性脑膜炎的常见后遗症。
  • 2010至2022年间,细菌性脑膜炎患儿的总体死亡率和听力损失率均显著下降。
  • 在本队列中,地塞米松使用与听力损失率降低无关。

研究设计与样本

  • 回顾性队列研究,使用儿科健康信息系统(PHIS)数据库,纳入2010至2022年因细菌性脑膜炎出院的儿童。
  • 共纳入6138例主要诊断为细菌性脑膜炎的患儿,其中男性3520例(57.3%),平均年龄5.8个月(范围2.0至61.2个月)。

主要发现

  • 277例(4.51%)患儿诊断为听力损失;听力损失组年龄显著大于无听力损失组(23.6个月 vs 5.3个月,p<0.01),性别、种族或民族与听力损失无关联。
  • 肺炎链球菌、流感嗜血杆菌和脑膜炎奈瑟菌感染与其他病原体相比,听力损失率显著更高(p<0.01)。
  • 听力损失组接受地塞米松治疗的比例高于无听力损失组。
  • 总体死亡率为2.1%;研究期间听力损失和死亡率均呈现显著下降。

临床怎么用

  • 作者指出听力损失仍是细菌性脑膜炎的常见后遗症,尽管预防肺炎链球菌、流感嗜血杆菌和脑膜炎奈瑟菌的疫苗已广泛接种。
  • 作者报告在本队列中地塞米松与听力损失率降低无关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Bacterial meningitis is a leading cause of acquired sensorineural hearing loss (SNHL). Treatment and prevention of bacterial meningitis have improved over time, but rates of neurologic complications have not been recently studied. The objective here is to present an updated population-based review of hearing loss as a sequela of bacterial meningitis. METHODS: A retrospective cohort study was conducted between 2010 and 2022 of children discharged with bacterial meningitis, using the Pediatric Health Information System's (PHIS) database. Rates of hearing loss and mortality were evaluated over time. RESULTS: A total of 6138 children with a primary diagnosis of bacterial meningitis were identified (3520 male [57.3%], mean age 5.8 months [2.0, 61.2]). Of these, 277 (4.51%) were diagnosed with hearing loss. Children with hearing loss were significantly older (23.6 vs. 5.3 months, p < 0.01), but differences in gender, race, or ethnicity had no association with hearing loss. Streptococcus pneumoniae, Hemophilus influenzae, and Neisseria meningiditis were associated with significantly higher rates of hearing loss than other etiologies (p < 0.01). Children with hearing loss had a higher rate of receiving dexamethasone than children without hearing loss. Overall mortality rate was 2.1%. Hearing loss and mortality demonstrated significant decreases over the study period. CONCLUSION: Hearing loss remains a common sequela of bacterial meningitis despite widespread uptake of vaccines for preventing S. pneumoniae, H. influenzae, and N. meningitidis. Dexamethasone was not associated with decreased rates of hearing loss in this cohort. From 2010 to 2022, there was a significant decrease in overall rates of mortality and hearing loss for children with bacterial meningitis. LEVEL OF EVIDENCE: 3: retrospective case-control series Laryngoscope, 134:3820-3825, 2024.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Gitomer SA, Boguniewicz J, Tong S, et al. Decrease in Rates of Hearing Loss From Pediatric Bacterial Meningitis Over Time: A Database Review. Laryngoscope. 2024. PMID: 38401054. doi:10.1002/lary.31353

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。